Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06014177 · ClinicalTrials.gov registry record · NA
A Digital Patient Decision Aid to Increase Sexually Transmitted Infection Testing in the Emergency Department: The STIckER Study
A NA study of STI and Sexually Transmitted Infection (STI), sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 184
- Enrollment target
- 2
- Study locations
NCT06014177: Completed NA study of STI and Sexually Transmitted Infection (STI), sponsored by Columbia University.
NCT06014177 is a NA study of STI and Sexually Transmitted Infection (STI) that has completed, run by Columbia University. The registered enrollment target is 184 participants, below the 336-participant average among 5 other STI trials with a reported enrollment target (45% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06014177, a NA study of STI and Sexually Transmitted Infection (STI), has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is a pilot randomized trial of STIckER in which 40 providers (20 trained in using the STIckER decision aid and 20 providing standard care) will enroll a total of 140 sexually active young Emergency Department (ED) patients over six months in a pediatric and adult ED setting. The primary goal is to determine if sexually active young individuals who use STIckER are more likely to undergo STI testing. By developing an effective automated digital tool to increase STI testing, the investigators aim to improve evidence-based sexual health education, reduce STI rates, and enhance the health outcomes of young individuals nationwide.
Primary Outcome
Percent of individuals with any gonorrhea or chlamydia testing performed in the ED on the day of their STIckER visit.
Conditions Studied
Interventions
- OTHER Control
- BEHAVIORAL STIckER
Study Locations (2)
New York
- Children's Hospital of New York (CHONY) - New York
- Milstein Hospital at NewYork-Presbyterian Hospital /Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2023-09-12 |
| Est. Completion | 2024-06-13 |
| Phase | NA |
What the finished NCT06014177 record still lists
NCT06014177 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 336-participant average among 5 other STI trials with a reported enrollment target (45% lower).
The record links to 3 conditions, with STI appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT06014177 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06014177 about?
NCT06014177 is a clinical study titled "A Digital Patient Decision Aid to Increase Sexually Transmitted Infection Testing in the Emergency Department: The STIckER Study". This study is a pilot randomized trial of STIckER in which 40 providers (20 trained in using the STIckER decision aid and 20 providing standard care) will enroll a total of 140 sexually active young Emergency Department (ED) patients over six months in a pediatric and adult ED setting. The primary g...
What is the current status of trial NCT06014177?
This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2023-09-12. Estimated completion is 2024-06-13.
What conditions does trial NCT06014177 study?
This clinical trial studies the following conditions: STI, Sexually Transmitted Infection (STI), Sexually Transmitted Disease (STD).
What interventions are being tested in trial NCT06014177?
The interventions under investigation include: Control (OTHER), STIckER (BEHAVIORAL).
Who is sponsoring clinical trial NCT06014177?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06014177 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for STI
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
RECRUITING · NA
-
Appalachian Partnership to Reduce Disparities (Aim 2)
RECRUITING · NA
-
Assessing the PrEP Care Cascade Among Black Men and Transwomen in the Southeastern US
ACTIVE NOT RECRUITING · NA
-
Evaluating the Effectiveness of a Mobile HIV Prevention App to Increase HIV and Sexually Transmitted Infections (STI) Testing and PrEP Initiation Among Rural Men Who Have Sex With Men
ACTIVE NOT RECRUITING · NA
-
HIV/STI Prevention Among Black Adolescents With Mental Illnesses (Project GOLD)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI